VALTOCO, a nasal spray formulation of diazepam, offers enhanced convenience and simplicity for managing seizure clusters, effectively meeting a crucial gap in epilepsy care. This attribute not only empowers individuals to manage their treatment autonomously but also offers reassurance and assistance to caregivers during crucial moments of intervention.
VALTOCO represents an exclusive formulation of diazepam, leveraging the innovative Intravail transmucosal absorption technology, distinguishing it as a dependable, secure, and easily accessible solution tailored to address the challenges associated with seizure clusters.
Delivering medication during a seizure of...
